Debate Prostate Cancer: Oligometastatic disease on PSMA PET/CT in setting of negative conventional staging studies should impact treatment decision: Agree or Disagree?

Moderator(s)

• 

  Thenappan Chandrasekar, MD,BS

  Thomas Jefferson University

Debater-Pro(s)

• 

  Nirmish Singla, MD,MSc

  Associate Professor of Urology and Oncology
  Johns Hopkins University School of Medicine

Debater-Con(s)

• 

  Sanoj Punnen, MD

  University of Miami